Cardioprotective effect of renin–angiotensin inhibitors and β-blockers in trastuzumab-related cardiotoxicity
Sign Up to like & getrecommendations! Published in 2019 at "Clinical Research in Cardiology"
DOI: 10.1007/s00392-019-01448-4
Abstract: BackgroundTrastuzumab-related cardiotoxicity (TRC) has been considered as reversible. However, recent studies have raised concern against reversibility of left ventricular (LV) systolic dysfunction in breast cancer patients treated with trastuzumab. In addition, the efficacy of medical… read more here.
Keywords: renin angiotensin; inhibitors blockers; angiotensin inhibitors; related cardiotoxicity ... See more keywords